Purchase of an Illumina MiSeq i100 plus
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for the purchase of an Illumina MiSeq i100 plus sequencing system. This acquisition supports the FDA's culture independent pathogen identification program and will enable rapid long read sequencing methods development for real-time screening of pathogens in field environmental samples, with particular application to pathogen detection in seafood. The solicitation is estimated to be released on March 1, 2026, with an anticipated award date of May 1, 2026.
The estimated award value for this contract ranges from $25,000 to $250,000. This procurement falls under NAICS code 541990 (All Other Professional, Scientific, and Technical Services) and does not utilize a set-aside program. Inquiries regarding this opportunity should be directed to the Food and Drug Administration's Acquisition Liaison at hfpacquisitions@fda.hhs.gov.
Forecast text
Purchase of Illumina MiSeq i100 plus which has the increased capability of sequencing pathogrens detected in seafood. This purchase is in support of our culture independent pathogen identification program and is needed for rapid long read sequencing methods development to support screening for pathogens in field environmental samples in real-time
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast